Literature DB >> 1347910

Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178.

R Medori1, P Montagna, H J Tritschler, A LeBlanc, P Cortelli, P Tinuper, E Lugaresi, P Gambetti.   

Abstract

Fatal familial insomnia (FFI), a condition characterized by inability to sleep, dysautonomia, motor disturbances, and selective thalamic atrophy is a prion disease linked to a GAC----AAC mutation at codon 178 of the prion gene. These data were obtained from one kindred. We now report a second kindred affected by FFI and carrying the same mutation. The finding of the same disease phenotype and genotype in a second family further validates FFI as a distinct disease entity and a phenotype of the GAC----AAC mutation at codon 178 of the prion gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347910     DOI: 10.1212/wnl.42.3.669

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection.

Authors:  Silvio M Zanata; Marilene H Lopes; Adriana F Mercadante; Glaucia N M Hajj; Luciana B Chiarini; Regina Nomizo; Adriana R O Freitas; Ana L B Cabral; Kil S Lee; Maria A Juliano; Elizabeth de Oliveira; Saul G Jachieri; Alma Burlingame; Lan Huang; Rafael Linden; Ricardo R Brentani; Vilma R Martins
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

Review 2.  The prion strain phenomenon: molecular basis and unprecedented features.

Authors:  Rodrigo Morales; Karim Abid; Claudio Soto
Journal:  Biochim Biophys Acta       Date:  2006-12-15

3.  [Fatal familial insomnia: case presentation and discussion of typical clinical and imaging findings].

Authors:  A V Thomas; J C Klein; A Brockhaus-Dumke; W D Heiss; A H Jacobs; H F Petereit
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

4.  Comparative analysis of gene expression profiles between cortex and thalamus in Chinese fatal familial insomnia patients.

Authors:  Chan Tian; Di Liu; Qing-Lan Sun; Chen Chen; Yin Xu; Hui Wang; Wei Xiang; Hans A Kretzschmar; Wei Li; Cao Chen; Qi Shi; Chen Gao; Jin Zhang; Bao-Yun Zhang; Jun Han; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-02-21       Impact factor: 5.590

5.  Analyses of the similarity and difference of global gene expression profiles in cortex regions of three neurodegenerative diseases: sporadic Creutzfeldt-Jakob disease (sCJD), fatal familial insomnia (FFI), and Alzheimer's disease (AD).

Authors:  Chan Tian; Di Liu; Wei Xiang; Hans A Kretzschmar; Qing-Lan Sun; Chen Gao; Yin Xu; Hui Wang; Xue-Yu Fan; Ge Meng; Wei Li; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2014-06-07       Impact factor: 5.590

Review 6.  Molecular biology and pathology of prion strains in sporadic human prion diseases.

Authors:  Pierluigi Gambetti; Ignazio Cali; Silvio Notari; Qingzhong Kong; Wen-Quan Zou; Witold K Surewicz
Journal:  Acta Neuropathol       Date:  2010-11-07       Impact factor: 17.088

7.  Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.

Authors:  Samia Hannaoui; Layal Maatouk; Nicolas Privat; Etienne Levavasseur; Baptiste A Faucheux; Stéphane Haïk
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

8.  Prion protein gene analysis in three kindreds with fatal familial insomnia (FFI): codon 178 mutation and codon 129 polymorphism.

Authors:  R Medori; H J Tritschler
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

9.  Analysis of the prion protein gene in thalamic dementia.

Authors:  R B Petersen; M Tabaton; L Berg; B Schrank; R M Torack; S Leal; J Julien; C Vital; B Deleplanque; W W Pendlebury
Journal:  Neurology       Date:  1992-10       Impact factor: 9.910

10.  Unexpected tolerance of alpha-cleavage of the prion protein to sequence variations.

Authors:  José B Oliveira-Martins; Sei-ichi Yusa; Anna Maria Calella; Claire Bridel; Frank Baumann; Paolo Dametto; Adriano Aguzzi
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.